Abstract:The emergence of antibiotic resistance highlights the critical need for novel antimicrobial agents. In this study, we investigated the synthesis of methyl α- D -glucopyranoside ( 1 ) analogs ( 2–6 ) which play vital roles in bacterial replication, in the context of DNA gyrase inhibitors. The unimolar one-step butyroylation of glucopyranoside furnished the 6- O -butyroyl derivative, which was further converted into five newer 6- O -butyroyl-2,3,4-tri-acyl-α- D -glucopyranoside analogs. The newly synthesized chemical structures were determined through physicochemical, elemental, and spectroscopic data. In vitro studies against bacteria and fungi with PASS (activity spectra for substances) prediction showed excellent antimicrobial activity of these glucopyranoside analogs. The cytotoxicity assessment indicated that the compounds exhibited less toxicity. In-depth molecular docking studies were carried out to elucidate the mechanism of action, binding energies, and interaction profiles of the synthesized compounds targeting gyrase. Additionally, a reference molecule, 4-methyl-5-[3-(methylsulfanyl)-1H-pyrazol-5-yl]-2-thiophen-2-yl-1,3-thiazole, was docked into the gyrase receptor to evaluate the inhibitory potential of the synthesized compounds. Moreover, a 100 ns molecular dynamics simulation process was performed to monitor the behavior of the complex structure, and a stable conformation and binding mode were found in the stimulating environment of the compounds. Pharmacokinetic predictions were investigated to evaluate the absorption, distribution, metabolism and toxicity of these compounds, and the combination of pharmacokinetic and drug-likeness predictions has shown promising results in silico. In summary, an integrated computational approach combining molecular docking, ADME-Tox assessment, DFT calculations, and molecular dynamics simulations highlights the promise of these derivatives as candidates for the development of new antimicrobial agents targeting DNA gyrase.

Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Studies on the antibacterial activities and molecular mechanism of GyrB inhibitors by 3D-QSAR, molecular docking and molecular dynamics simulation

Identification of promising anti-DNA gyrase antibacterial compounds using de novo design, molecular docking and molecular dynamics studies

Discovery of Benzopyrone-Based Candidates as Potential Antimicrobial and Photochemotherapeutic Agents through Inhibition of DNA Gyrase Enzyme B: Design, Synthesis, In Vitro and In Silico Evaluation

Pyrrolamide DNA gyrase inhibitors: fragment-based nuclear magnetic resonance screening to identify antibacterial agents.

Exploring the interaction of N -(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study

New ATP-competitive inhibitors of E. coli GyrB obtained from the mapping of the hydrophobic floor at the binding site: synthesis and biological evaluation

New N-amino-5-cyano-6-pyridones as antimicrobial small molecules endowed with DNA gyrase a inhibitory activity: design, one-pot synthesis, biological assessment and in silico insights

In-silico driven design and development of spirobenzimidazo-quinazolines as potential DNA gyrase inhibitors

Experimental and Molecular Docking Studies of Cyclic Diphenyl Phosphonates as DNA Gyrase Inhibitors for Fluoroquinolone-Resistant Pathogens

In silico evaluation of usnic acid derivatives to discover potential antibacterial drugs against DNA gyrase B and DNA topoisomerase IV

Synthesis, Structure And Antibacterial Activity Of Potent Dna Gyrase Inhibitors: N '-Benzoyl-3-(4-Bromophenyl)-1h-Pyrazole-5-Carbohydrazide Derivatives

Identification of new building blocks by fragment screening for discovering GyrB inhibitors

Biological Activities of Novel Gyrase Inhibitors of the Aminocoumarin Class

Design, synthesis, molecular docking, and antibacterial activity of novel amide-linked tetrahydrobenzothienopyrimidinone derivatives as potential DNA gyrase and topoisomerase IV inhibitors

Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.

DESIGN, INSILICO SCREENING, MOLECULAR DOCKING, SYNTHESIS AND BIOLOGICAL EVALUATION OF BENZO-FUSED FIVE MEMBERED NITROGEN CONTAINING HETEROCYCLE AGAINST DNA GYRASE SUBUNIT B AS POTENTIAL ANTIMICROBIAL AGENT

Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay

New pyrrole derivatives as DNA gyrase and 14α‐demethylase inhibitors: Design, synthesis, antimicrobial evaluation, and molecular docking

Molecular docking, ADME-Tox, DFT and molecular dynamics simulation of butyroyl glucopyranoside derivatives against DNA gyrase inhibitors as antimicrobial agents